Results 181 to 190 of about 4,356,687 (302)

Orbital-order as the driving mechanism for superconductivity in ruthenates. [PDF]

Nat Commun
Carrasco Álvarez ÁA, Petit S, Prellier W, Bibes M, Varignon J.   +4 more
europepmc   +1 more source

The coupling relationship and driving mechanism between urbanization and ecosystem services in the Yellow River Basin from a multi-spatial scale perspective. [PDF]

PLoS One, 2023
Zhang J, Zhang Z, Liu L, Bai X, Wang S, Kang L, Cai X.   +6 more
europepmc   +1 more source

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

Molecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba, Mark Shacker, Timothy P. Fleming, Michael A. Smith, Ross M. Bremner, Narendra V. Sankpal   +5 more
wiley   +1 more source

Research on the accelerating effect and driving mechanism of the African swine fever epidemic on the capitalization of hog farming: evidence from China. [PDF]

Front Vet Sci
Hua J, Tian M, Jia Y, Chen Y.
europepmc   +1 more source

Driving mechanism of consumer migration behavior under the COVID-19 pandemic. [PDF]

Front Public Health, 2022
Wang D, Chen W, Zheng X, Wang X.
europepmc   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

Molecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David, Arthur Karaulic, Audrey Bennetot, Clémence Fournier, Quentin Odet, Arthur Gouraud, Isabelle Bourget, Cédric Gaggioli, Sandy Giuliano, Frédéric Luciano, Olivier Léger, Zaki Sellam, Gilles Pagès   +12 more
wiley   +1 more source

The behavioral driving mechanism of ecological co-management among multiple subjects from the perspective of social network embedding: Evidence from coffee-producing areas in China. [PDF]

PLoS One
Xu X, Wang D.
europepmc   +1 more source

The Driving Mechanism of Urban Land Expansion from 2005 to 2018: The Case of Yangzhou, China. [PDF]

Int J Environ Res Public Health, 2022
Meng L, Si W.
europepmc   +1 more source

Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy

Molecular Oncology, EarlyView.
LCOR (Ligand‐dependent corepressor) mRNA encapsulated in polymeric nanoparticles restores LCOR activity in tumor cells, constraining aggressive tumor cell states and increasing tumor immunogenicity. This reprogramming makes tumor cells more vulnerable to T‐cell attack and enhances their response to immune‐checkpoint immunotherapy.
Gabriel Serra‐Mir, Elena Haro‐Martínez, Sandra Blasco‐Benito, Chiara Cannatà, José Ángel Palomeque, Anna López‐Plana, Maria Sanz‐Flores, Marc Sabartés, Cristina Fornaguera, Toni Celià‐Terrassa   +9 more
wiley   +1 more source

Understanding the trade-off and synergy effects of landscape multifunctional and its driving mechanism in rapidly urbanizing areas. [PDF]

Sci Rep
Zhang H, Wu S, Chen S, Wu C, Xu F.
europepmc   +1 more source